Wegovy is a once-weekly subcutaneous injection at a higher dose (2.4 mg) approved for chronic weight management and cardiovascular risk reduction
Nephron 144 , 595606 (2020)
We do have to be careful about excess body weight loss, which we know sarcopenia, bone health, and so forth but we really haven't seen any other signals to date, and we're going to continue and look for those
Role of oxidants and antioxidants in female reproduction
Omega-3 Fatty Acids A common nutritional deficiency in people with chronic fatigue is omega-3 fatty acids
Exenatide, a synthetic version of exendin-4, a GLP-1 receptor agonist, is widely used to treat diabetes and obesity and has the potential to be repurposed for the treatment of increased ICP (Fig